cbdMD, Inc. (YCBD) |
| 0.792 -0.034 (-4.12%) 05-29 16:00 |
| Open: | 0.81 |
| High: | 0.8233 |
| Low: | 0.766 |
| Volume: | 231,194 |
| Market Cap: | 8(M) |
| PE Ratio: | 0.32 |
| Exchange: | New York Stock Exchange American |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 1.06 |
| Resistance 1: | 0.92 |
| Pivot price: | 0.78 |
| Support 1: | 0.70 |
| Support 2: | 0.58 |
| 52w High: | 2.56 |
| 52w Low: | 0.47 |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Wed, 20 May 2026
Lease change at cbdMD (NYSE: YCBD) cuts annual rent and shrinks footprint - Stock Titan
Thu, 14 May 2026
Press Release: CbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - Moomoo
Thu, 14 May 2026
cbdMD (YCBD) grows revenue but warns on going concern and hemp rule risks - Stock Titan
Thu, 14 May 2026
cbdMD, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Thu, 14 May 2026
Medicare pilot allows $500 for CBD care; cbdMD targets BEI demand - Stock Titan
Tue, 12 May 2026
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |